# A Phase 3 Efficacy Study of Pilocarpine HCl Ophthalmic Solution (AGN-190584) in Participants With Presbyopia

> **NCT03857542** · PHASE3 · COMPLETED · sponsor: **Allergan** · enrollment: 427 (actual)

## Conditions studied

- Presbyopia

## Interventions

- **DRUG:** Pilocarpine HCl Ophthalmic Solution
- **OTHER:** Vehicle

## Key facts

- **NCT ID:** NCT03857542
- **Lead sponsor:** Allergan
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-03-01
- **Primary completion:** 2020-09-10
- **Final completion:** 2020-09-10
- **Target enrollment:** 427 (ACTUAL)
- **Last updated:** 2021-12-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03857542

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03857542, "A Phase 3 Efficacy Study of Pilocarpine HCl Ophthalmic Solution (AGN-190584) in Participants With Presbyopia". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03857542. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*